S&P 500   3,958.75 (+0.63%)
DOW   33,800.56 (+0.60%)
QQQ   283.19 (+0.95%)
AAPL   142.63 (+1.20%)
MSFT   247.34 (+1.22%)
META   115.94 (+1.76%)
GOOGL   94.14 (-0.84%)
AMZN   89.89 (+1.62%)
TSLA   170.45 (-2.06%)
NVDA   167.71 (+4.04%)
NIO   13.21 (+5.01%)
BABA   93.37 (+5.71%)
AMD   70.22 (+0.11%)
T   19.18 (-0.62%)
MU   55.51 (+3.14%)
CGC   3.19 (-1.54%)
F   13.13 (+0.23%)
GE   83.34 (-1.95%)
DIS   92.67 (+0.56%)
AMC   6.25 (+3.31%)
PYPL   75.13 (+0.95%)
PFE   50.95 (+1.41%)
NFLX   307.49 (-0.30%)
S&P 500   3,958.75 (+0.63%)
DOW   33,800.56 (+0.60%)
QQQ   283.19 (+0.95%)
AAPL   142.63 (+1.20%)
MSFT   247.34 (+1.22%)
META   115.94 (+1.76%)
GOOGL   94.14 (-0.84%)
AMZN   89.89 (+1.62%)
TSLA   170.45 (-2.06%)
NVDA   167.71 (+4.04%)
NIO   13.21 (+5.01%)
BABA   93.37 (+5.71%)
AMD   70.22 (+0.11%)
T   19.18 (-0.62%)
MU   55.51 (+3.14%)
CGC   3.19 (-1.54%)
F   13.13 (+0.23%)
GE   83.34 (-1.95%)
DIS   92.67 (+0.56%)
AMC   6.25 (+3.31%)
PYPL   75.13 (+0.95%)
PFE   50.95 (+1.41%)
NFLX   307.49 (-0.30%)
S&P 500   3,958.75 (+0.63%)
DOW   33,800.56 (+0.60%)
QQQ   283.19 (+0.95%)
AAPL   142.63 (+1.20%)
MSFT   247.34 (+1.22%)
META   115.94 (+1.76%)
GOOGL   94.14 (-0.84%)
AMZN   89.89 (+1.62%)
TSLA   170.45 (-2.06%)
NVDA   167.71 (+4.04%)
NIO   13.21 (+5.01%)
BABA   93.37 (+5.71%)
AMD   70.22 (+0.11%)
T   19.18 (-0.62%)
MU   55.51 (+3.14%)
CGC   3.19 (-1.54%)
F   13.13 (+0.23%)
GE   83.34 (-1.95%)
DIS   92.67 (+0.56%)
AMC   6.25 (+3.31%)
PYPL   75.13 (+0.95%)
PFE   50.95 (+1.41%)
NFLX   307.49 (-0.30%)
S&P 500   3,958.75 (+0.63%)
DOW   33,800.56 (+0.60%)
QQQ   283.19 (+0.95%)
AAPL   142.63 (+1.20%)
MSFT   247.34 (+1.22%)
META   115.94 (+1.76%)
GOOGL   94.14 (-0.84%)
AMZN   89.89 (+1.62%)
TSLA   170.45 (-2.06%)
NVDA   167.71 (+4.04%)
NIO   13.21 (+5.01%)
BABA   93.37 (+5.71%)
AMD   70.22 (+0.11%)
T   19.18 (-0.62%)
MU   55.51 (+3.14%)
CGC   3.19 (-1.54%)
F   13.13 (+0.23%)
GE   83.34 (-1.95%)
DIS   92.67 (+0.56%)
AMC   6.25 (+3.31%)
PYPL   75.13 (+0.95%)
PFE   50.95 (+1.41%)
NFLX   307.49 (-0.30%)
NYSE:CHE

Chemed - CHE Stock Forecast, Price & News

$520.69
+2.05 (+0.40%)
(As of 12/8/2022 12:05 PM ET)
Add
Compare
Today's Range
$514.22
$521.66
50-Day Range
$432.50
$524.10
52-Week Range
$430.16
$539.87
Volume
1,476 shs
Average Volume
80,329 shs
Market Capitalization
$7.74 billion
P/E Ratio
30.26
Dividend Yield
0.29%
Price Target
$545.00

Chemed MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
5.1% Upside
$545.00 Price Target
Short Interest
Bearish
2.53% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.33
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$5.39 M Sold Last Quarter
Proj. Earnings Growth
8.97%
From $18.72 to $20.40 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.47 out of 5 stars

Medical Sector

141st out of 1,027 stocks

Home Health Care Services Industry

4th out of 9 stocks

CHE stock logo

About Chemed (NYSE:CHE) Stock

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Receive CHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

CHE Stock News Headlines

PNTG vs. CHE: Which Stock Is the Better Value Option?
Chemed (CHE) Q3 Earnings Surpass Estimates, EPS View Up
Chemed Q3 2022 Earnings Preview
Chemed Corp.
See More Headlines
Receive CHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

CHE Company Calendar

Last Earnings
10/31/2022
Ex-Dividend for 12/5 Dividend
11/10/2022
Dividend Payable
12/05/2022
Today
12/08/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/23/2023

Industry, Sector and Symbol

Industry
Home health care services
Sub-Industry
Health Care Services
Sector
Medical
CUSIP
16359R10
Employees
14,137
Year Founded
1970

Price Target and Rating

Average Stock Price Forecast
$545.00
High Stock Price Forecast
$545.00
Low Stock Price Forecast
$545.00
Forecasted Upside/Downside
+4.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$268.55 million
Pretax Margin
16.13%

Debt

Sales & Book Value

Annual Sales
$2.14 billion
Cash Flow
$23.39 per share
Book Value
$39.62 per share

Miscellaneous

Free Float
14,271,000
Market Cap
$7.74 billion
Optionable
Optionable
Beta
0.55

Social Links


Key Executives

  • Mr. Kevin J. McNamaraMr. Kevin J. McNamara (Age 68)
    CEO, Pres & Director
    Comp: $6.11M
  • Mr. David P. Williams (Age 61)
    Exec. VP & CFO
    Comp: $2.91M
  • Mr. Michael D. Witzeman CPA (Age 51)
    MBA, VP & Controller
    Comp: $1.06M
  • Mr. Nicholas Michael WestfallMr. Nicholas Michael Westfall (Age 43)
    Exec. VP
    Comp: $1.81M
  • Ms. Lisa A. Reinhard
    VP, Chief Admin. Officer & Assistant Sec.
  • Sherri Warner
    Director of Investor Relations
  • Mr. Brian C. Judkins (Age 41)
    VP, Sec. & Chief Legal Officer
  • Mr. Thomas C. Hutton (Age 71)
    VP & Director













CHE Stock - Frequently Asked Questions

Should I buy or sell Chemed stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CHE shares.
View CHE analyst ratings
or view top-rated stocks.

What is Chemed's stock price forecast for 2023?

1 Wall Street analysts have issued 12-month price targets for Chemed's shares. Their CHE share price forecasts range from $545.00 to $545.00. On average, they predict the company's share price to reach $545.00 in the next year. This suggests a possible upside of 5.1% from the stock's current price.
View analysts price targets for CHE
or view top-rated stocks among Wall Street analysts.

How have CHE shares performed in 2022?

Chemed's stock was trading at $529.04 at the beginning of the year. Since then, CHE stock has decreased by 2.0% and is now trading at $518.64.
View the best growth stocks for 2022 here
.

Are investors shorting Chemed?

Chemed saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 368,100 shares, an increase of 20.5% from the October 31st total of 305,500 shares. Based on an average daily volume of 84,400 shares, the days-to-cover ratio is currently 4.4 days. Currently, 2.5% of the shares of the stock are short sold.
View Chemed's Short Interest
.

When is Chemed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our CHE earnings forecast
.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) issued its earnings results on Monday, October, 31st. The company reported $4.74 EPS for the quarter, beating analysts' consensus estimates of $4.61 by $0.13. The business earned $526.47 million during the quarter, compared to the consensus estimate of $527.05 million. Chemed had a trailing twelve-month return on equity of 44.29% and a net margin of 12.31%. The business's quarterly revenue was down 2.3% compared to the same quarter last year. During the same period in the previous year, the company posted $5.06 EPS.

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed announced a quarterly dividend on Friday, November 4th. Shareholders of record on Monday, November 14th will be given a dividend of $0.38 per share on Monday, December 5th. This represents a $1.52 annualized dividend and a dividend yield of 0.29%. The ex-dividend date of this dividend is Thursday, November 10th.
Read our dividend analysis for CHE
.

Is Chemed a good dividend stock?

Chemed (NYSE:CHE) pays an annual dividend of $1.52 per share and currently has a dividend yield of 0.29%. The company has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 8.83%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CHE will have a dividend payout ratio of 7.45% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CHE.

What guidance has Chemed issued on next quarter's earnings?

Chemed updated its FY 2022 earnings guidance on Monday, November, 7th. The company provided earnings per share guidance of $19.60-$19.70 for the period, compared to the consensus EPS estimate of $19.49. The company issued revenue guidance of -.

What is Kevin J. McNamara's approval rating as Chemed's CEO?

1 employees have rated Chemed Chief Executive Officer Kevin J. McNamara on Glassdoor.com. Kevin J. McNamara has an approval rating of 100% among the company's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX).

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Who are Chemed's major shareholders?

Chemed's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.30%), BlackRock Inc. (8.99%), Neuberger Berman Group LLC (3.66%), Kayne Anderson Rudnick Investment Management LLC (3.44%), State Street Corp (2.81%) and Victory Capital Management Inc. (1.39%). Insiders that own company stock include Andrea R Lindell, David Patrick Williams, Donald E Saunders, Frank E Wood, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee and Thomas P Rice.
View institutional ownership trends
.

How do I buy shares of Chemed?

Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $518.64.

How much money does Chemed make?

Chemed (NYSE:CHE) has a market capitalization of $7.71 billion and generates $2.14 billion in revenue each year. The company earns $268.55 million in net income (profit) each year or $17.21 on an earnings per share basis.

How many employees does Chemed have?

The company employs 14,137 workers across the globe.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The official website for the company is www.chemed.com. The company can be reached via phone at (513) 762-6690 or via fax at 513-762-6590.

This page (NYSE:CHE) was last updated on 12/8/2022 by MarketBeat.com Staff